You are here: Industry Insights > stomach cancer

News List

Imugene says HER-Vaxx cancer vaccine induces 50% ORR in stomach cancer trial firstwordpharma
July 06, 2021
Imugene reported updated Phase II results for HER-Vaxx on Monday, saying that adding the experimental B-cell peptide immunotherapy vaccine to chemotherapy led to an overall response rate (ORR) of 50% in certain patients with gastric cancer.
Debbie's Dream Foundation Publishes 2020 Annual Report Highlighting the Organization's Most Successful Year Despite the COVID-19 Global Pandemic prnewswire
May 27, 2021
Debbie's Dream Foundation: Curing Stomach Cancer (DDF) published its 2020 annual report highlighting how the organization successfully transitioned to operating virtually during the COVID-19 global pandemic.
Stomach Cancer Appears Different in Younger Patients drugs
January 02, 2020
Stomach cancer among many people under 60 appears more deadly than when it occurs to older people, a new study finds.
Researchers claim that an acid reflex drug is linked to more than doubled risk of stomach cancer biospectrumasia
November 07, 2017
There are more than 50m prescriptions for proton pump inhibitors in the UK, though they have previously been linked to side-effects and increased risk of death.
LonzaNEWS Long-term use of PPIs linked to stomach cancer europeanpharmaceuticalreview
November 01, 2017
The long-term use of proton pump inhibitors, a class of drugs commonly used to treat acid reflux, is linked to the risk of developing stomach cancer…